OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) insider Jeffrey Yu bought 45,126 shares of the firm’s stock in a transaction that occurred on Friday, October 9th. The shares were acquired at an average price of $5.54 per share, with a total value of $249,998.04. Following the acquisition, the insider owned 896,840 shares of the company’s stock, valued at $4,968,493.60. This represents a 5.30% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Jeffrey Yu also recently made the following trade(s):
- On Thursday, September 10th, Jeffrey Yu purchased 14,285 shares of OneMedNet stock. The stock was acquired at an average cost of $6.30 per share, with a total value of $89,995.50.
OneMedNet Stock Up 0.8%
Shares of ONMD stock opened at $4.75 on Friday. The stock has a fifty day moving average of $6.03 and a 200 day moving average of $7.19. OneMedNet Corporation has a 52 week low of $3.61 and a 52 week high of $28.20.
Analysts Set New Price Targets
Read Our Latest Report on OneMedNet
OneMedNet Company Profile
OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.
The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.
Further Reading
- Five stocks we like better than OneMedNet
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
